Abstract

Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2010 - Supporting Quality Pharmaceutical Compounding World Wide

Page(s): 428

Download in electronic PDF format for $75
  • Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection Page 1

Abstract

A formulation for preparing Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • panitumumab
  • cancer
  • recombinant human monoclonal antibody
  • epidermal growth factor receptor
  • antineoplastic agent

Related Categories

  • CANCER AND AIDS
  • EAR NOSE THROAT
  • FORMULATIONS
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2010
Pg. 428
Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection
Author(s): Allen Loyd V Jr
Nov/Dec 2022
Pg. 446-466
Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Mar/Apr 1997
Pg. 132-134
Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
Author(s): Zhang Yan-ping, Trissel Lawrence A
Jul/Aug 2001
Pg. 323-324
Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions
Author(s): Quay Irene, Tan Edward
May/Jun 1997
Pg. 208-209
Stability of Cefmetazole Sodium in 5% dextrose Injection and 0.9% Sodium Chloride Injection
Author(s): Gupta Vishnu D, Maswoswe J, Bailey RE
Jul/Aug 2021
Pg. 330-335
Stability of Dexmedetomidine in Polyvinyl Chloride Bags Containing 0.9% Sodium Chloride Intended for Subcutaneous Infusions
Author(s): Wolfe Amanda, Zhang Jeremy, Lapenskie Julie, Downar James, Kanji Salmaan
Mar/Apr 1998
Pg. 168-169
Stability of Milrinone Lactate 200 mcg/mL in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
Author(s): Wong Frances, Gill Mark A
Sep/Oct 2010
Pg. 427
Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2017
Pg. 150-153
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers
Author(s): McCluskey Susan V, Kirkham Kylian, Munson Jessica M
Jan/Feb 2023
Pg. 53
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 426-429
Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes
Author(s): Kirkham Kylian, Munson Jessica M, McCluskey Susan V, Graner Kevin K
Jan/Feb 2019
Pg. 60
Piperacillin 10 mg/mL in 0.9% Sodium Chloride Bladder Irrigation
Author(s): Allen Loyd V Jr
Jul/Aug 2008
Pg. 357
Sodium Chloride 0.9% Ointment
Author(s): Allen Loyd V Jr
May/Jun 1997
Pg. 206-207
Stability of Ketorolac Tromethamine in 5% Dextrose Injection and 0.9% Sodium Chloride Injections
Author(s): Gupta Vishnu D, Maswoswe J, Bailey RE
Nov/Dec 1997
Pg. 435-436
Stability of Cefepime Hydrochloride Dextrose in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
Author(s): Gupta Vishnu D, Maswoswe J, Bailey RE
Sep/Oct 2017
Pg. 436-439
Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags
Author(s): Marquis Kathleen, Hohlfelder Benjamin, Szumita Paul M
Jan/Feb 2000
Pg. 66-68
Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection
Author(s): Gupta Vishnu D, Bailey RE